Eman Al-Hassan

Eman Al-Hassan

Hogan Lovells

Contact
View Bio
RSS

Latest Posts › Regulatory Oversight

Share:

FDA warns of “important” clinical trial protocol deviations

The U.S. Food and Drug Administration (FDA) published the draft guidance “Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and Devices,” which provides advice for sponsors, investigators, and...more

1/14/2025  /  Clinical Trials , Data Management , Food and Drug Administration (FDA) , Life Sciences , Medical Devices , Regulatory Oversight , Regulatory Requirements , Reporting Requirements , Risk Management
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide